MicrobiologybioRxiv
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
H. Ohashi, T. Hishiki, D. Akazawa…·K. Watashi
The paper compares the efficacy of neutralizing antibodies and antiviral drugs against SARS-CoV-2 Omicron subvariants BA.1 and BA.2, finding differential responses to specific treatments.
DOI 10.1016/j.antiviral.2022.105372